Sofinnova Investments, Inc. Quant / Systematic

Location: Menlo Park, CA

CIK: 0001631134 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value: $1.663B (100.0% shares, 0.0% debt)

Holdings (64)

NTRA Natera 18.9%
Value $315M Shares 3,100,560 Share Price $101.54 * Est. Cost/Share $9.81 Unrealized @ Report Date +1017.1%
— Karuna Therapeutics, Inc. 14.1%
Value $235M Shares 1,952,441 Share Price $120.23 Est. Cost/Share $26.41 Unrealized @ Report Date —
— Bolt Biotherapeutics, Inc. 5.4%
Value $90.65M Shares 2,754,437 Share Price $32.91 Est. Cost/Share $32.91 Unrealized @ Report Date —
ASND Ascendis Pharma A/S 4.0%
Value $67.27M Shares 521,923 Share Price $128.88 Est. Cost/Share $69.98 Unrealized @ Report Date —
— Y-mAbs Therapeutics, Inc 4.0%
Value $66.36M Shares 2,194,278 Share Price $30.24 Est. Cost/Share $26.75 Unrealized @ Report Date —
AZN AstraZeneca PLC 3.1%
Value $51.5M Shares 1,035,732 Share Price $49.72 Est. Cost/Share $49.94 Unrealized @ Report Date —
— Health Care Select Sector SPDR 2.8%
Value $46.7M Shares 400,000 Share Price $116.74 Est. Cost/Share — Unrealized @ Report Date —
— Checkmate Pharmaceuticals Inc 2.6%
Value $43.78M Shares 3,606,707 Share Price $12.14 Est. Cost/Share $11.51 Unrealized @ Report Date —
JAZZ Jazz Pharmaceuticals PLC 2.5%
Value $42.07M Shares 255,928 Share Price $164.37 Est. Cost/Share $132.04 Unrealized @ Report Date +24.6%
— Inozyme Pharma, Inc. 2.4%
Value $40.16M Shares 2,028,308 Share Price $19.80 Est. Cost/Share $26.29 Unrealized @ Report Date —
UTHR United Therapeutics Corp 2.2%
Value $35.97M Shares 215,054 Share Price $167.27 Est. Cost/Share $94.24 Unrealized @ Report Date +76.9%
LLY Eli Lilly and Co 2.0%
Value $33.72M Shares 180,501 Share Price $186.82 Est. Cost/Share $177.44 Unrealized @ Report Date +4.9%
— Nucana Biomed Ltd 1.7%
Value $27.94M Shares 5,599,999 Share Price $4.99 Est. Cost/Share $9.47 Unrealized @ Report Date —
— Merus N.V. 1.6%
Value $27.39M Shares 1,311,039 Share Price $20.89 Est. Cost/Share $18.53 Unrealized @ Report Date —
GRTX Galera Therapeutics, Inc 1.6%
Value $27.2M Shares 3,083,712 Share Price $8.82 * Est. Cost/Share $12.19 Unrealized @ Report Date -10.0%
— Nextcure, Inc 1.6%
Value $26.75M Shares 2,671,856 Share Price $10.01 Est. Cost/Share $10.01 Unrealized @ Report Date —
ALGN Align Technology Inc 1.5%
Value $24.64M Shares 45,500 Share Price $541.54 * Est. Cost/Share $552.79 Unrealized @ Report Date 0.0%
— Acceleron Pharma Inc 1.5%
Value $24.21M Shares 178,538 Share Price $135.61 Est. Cost/Share $119.61 Unrealized @ Report Date —
— Reata Pharmaceuticals Inc 1.4%
Value $23.78M Shares 238,520 Share Price $99.70 Est. Cost/Share $110.30 Unrealized @ Report Date —
— Mirati Therapeutics Inc 1.4%
Value $23.64M Shares 138,030 Share Price $171.30 Est. Cost/Share $171.30 Unrealized @ Report Date —
— Intra-Cellular Therapies Inc 1.3%
Value $22.22M Shares 655,001 Share Price $33.93 Est. Cost/Share $27.53 Unrealized @ Report Date —
PTCT PTC Therapeutics Inc 1.3%
Value $22.11M Shares 466,840 Share Price $47.35 * Est. Cost/Share $48.68 Unrealized @ Report Date +22.0%
INSM Insmed Inc 1.3%
Value $21.08M Shares 618,950 Share Price $34.06 * Est. Cost/Share $31.50 Unrealized @ Report Date +21.3%
— Akouos, Inc 1.3%
Value $21.01M Shares 1,515,074 Share Price $13.87 Est. Cost/Share $22.50 Unrealized @ Report Date —
— Gilead Sciences Inc 1.2%
Value $19.39M Shares 300,000 Share Price $64.63 Est. Cost/Share — Unrealized @ Report Date —
EXEL Exelixis Inc 1.1%
Value $18.96M Shares 839,181 Share Price $22.59 Est. Cost/Share $22.58 Unrealized @ Report Date 0.0%
PTGX Protagonist Therapeutics Inc 1.0%
Value $16.96M Shares 654,900 Share Price $25.90 * Est. Cost/Share $25.31 Unrealized @ Report Date 0.0%
— ObsEva SA 0.9%
Value $15.44M Shares 4,749,623 Share Price $3.25 Est. Cost/Share $13.49 Unrealized @ Report Date —
QURE Uniqure NV 0.9%
Value $14.39M Shares 427,122 Share Price $33.69 * Est. Cost/Share $35.84 Unrealized @ Report Date 0.0%
RGNX Regenxbio Inc 0.7%
Value $12.34M Shares 361,735 Share Price $34.11 * Est. Cost/Share $36.49 Unrealized @ Report Date +16.9%
— Horizon Therapeutics PLC 0.7%
Value $12.33M Shares 133,997 Share Price $92.04 Est. Cost/Share $73.15 Unrealized @ Report Date —
— Nucana Biomed Ltd 0.7%
Value $11.98M Shares 2,400,000 Share Price $4.99 Est. Cost/Share $4.99 Unrealized @ Report Date —
VRTX Vertex Pharmaceuticals Inc 0.6%
Value $9.82M Shares 45,700 Share Price $214.88 * Est. Cost/Share $219.65 Unrealized @ Report Date 0.0%
DXCM Dexcom Inc 0.6%
Value $9.704M Shares 27,000 Share Price $359.41 * Est. Cost/Share $93.87 Unrealized @ Report Date 0.0%
AMGN Amgen Inc 0.6%
Value $9.671M Shares 38,868 Share Price $248.82 * Est. Cost/Share $205.28 Unrealized @ Report Date -0.3%
— Agenus Inc 0.6%
Value $9.461M Shares 3,478,201 Share Price $2.72 Est. Cost/Share $2.72 Unrealized @ Report Date —
MIRM Mirum Pharmaceuticals Inc 0.6%
Value $9.442M Shares 476,401 Share Price $19.82 * Est. Cost/Share $17.49 Unrealized @ Report Date +9.4%
— Athira Pharma, Inc. 0.6%
Value $9.369M Shares 509,168 Share Price $18.40 Est. Cost/Share $18.46 Unrealized @ Report Date —
— ChemoCentryx Inc 0.6%
Value $9.223M Shares 179,999 Share Price $51.24 Est. Cost/Share $50.39 Unrealized @ Report Date —
CYTK Cytokinetics Inc 0.5%
Value $9.065M Shares 389,720 Share Price $23.26 * Est. Cost/Share $20.33 Unrealized @ Report Date +5.0%
— ChemoCentryx Inc 0.5%
Value $7.686M Shares 150,000 Share Price $51.24 Est. Cost/Share — Unrealized @ Report Date —
— TCR2 Therapeutics Inc 0.4%
Value $7.434M Shares 336,682 Share Price $22.08 Est. Cost/Share $25.43 Unrealized @ Report Date —
— Amarin Corp 0.4%
Value $7.269M Shares 1,170,584 Share Price $6.21 Est. Cost/Share $7.81 Unrealized @ Report Date —
SNDX Syndax Pharmaceuticals Inc 0.4%
Value $6.678M Shares 298,644 Share Price $22.36 Est. Cost/Share $20.74 Unrealized @ Report Date +8.9%
CHRS Coherus BioSciences 0.4%
Value $6.349M Shares 434,555 Share Price $14.61 * Est. Cost/Share $10.94 Unrealized @ Report Date +55.2%
— Arena Pharmaceuticals Inc 0.4%
Value $6.346M Shares 91,448 Share Price $69.39 Est. Cost/Share $73.99 Unrealized @ Report Date —
— Marinus Pharmaceuticals Inc 0.3%
Value $5.733M Shares 370,351 Share Price $15.48 Est. Cost/Share $13.05 Unrealized @ Report Date —
— Jounce Therapeutics Inc 0.3%
Value $5.256M Shares 511,822 Share Price $10.27 Est. Cost/Share $7.00 Unrealized @ Report Date —
PODD Insulet Corp 0.3%
Value $4.566M Shares 17,500 Share Price $260.91 * Est. Cost/Share $267.81 Unrealized @ Report Date 0.0%
FATE Fate Therapeutics Inc 0.3%
Value $4.518M Shares 54,795 Share Price $82.45 * Est. Cost/Share $80.81 Unrealized @ Report Date +18.6%
REPL Replimune Group Inc 0.3%
Value $4.339M Shares 142,209 Share Price $30.51 * Est. Cost/Share $38.04 Unrealized @ Report Date -1.6%
IMTX Immatics NV 0.3%
Value $4.317M Shares 385,099 Share Price $11.21 Est. Cost/Share $10.75 Unrealized @ Report Date +5.5%
— Aligos Therapeutics Inc 0.3%
Value $4.219M Shares 185,532 Share Price $22.74 Est. Cost/Share $27.65 Unrealized @ Report Date —
— Aptose Biosciences Inc 0.3%
Value $4.164M Shares 696,928 Share Price $5.97 Est. Cost/Share $4.38 Unrealized @ Report Date —
— Heron Therapeutics Inc 0.2%
Value $4.053M Shares 250,000 Share Price $16.21 Est. Cost/Share — Unrealized @ Report Date —
BCRX BioCryst Pharmaceuticals Inc 0.2%
Value $3.852M Shares 378,774 Share Price $10.17 Est. Cost/Share $4.01 Unrealized @ Report Date +157.0%
SVRA Savara Inc 0.2%
Value $3.614M Shares 1,737,450 Share Price $2.08 * Est. Cost/Share $1.71 Unrealized @ Report Date 0.0%
PBYI Puma Biotechnology Inc 0.2%
Value $3.353M Shares 344,917 Share Price $9.72 * Est. Cost/Share $10.04 Unrealized @ Report Date +11.2%
— Otonomy Inc 0.2%
Value $3.191M Shares 1,251,256 Share Price $2.55 Est. Cost/Share $3.81 Unrealized @ Report Date —
KURA Kura Oncology Inc 0.1%
Value $2.351M Shares 83,164 Share Price $28.27 * Est. Cost/Share $14.42 Unrealized @ Report Date +119.3%
MGNX MacroGenics Inc 0.1%
Value $2.331M Shares 73,201 Share Price $31.84 * Est. Cost/Share $23.02 Unrealized @ Report Date +5.5%
— Synlogic Inc. 0.1%
Value $2.058M Shares 574,972 Share Price $3.58 Est. Cost/Share $9.38 Unrealized @ Report Date —
— Calithera Biosciences Inc 0.1%
Value $1.833M Shares 757,533 Share Price $2.42 Est. Cost/Share $3.79 Unrealized @ Report Date —
PDSB PDS Biotechnology Corporation 0.0%
Value $649K Shares 142,635 Share Price $4.55 * Est. Cost/Share $8.36 Unrealized @ Report Date -51.9%